NVO

Finance

Why cutting drug prices is pushing Eli Lilly’s stock toward an all-time high

November 11, 2025
eswar6424

Published: Nov. 11, 2025 at 3:20 p.m. ET Eli Lilly & Co.’s stock is once again in…

Finance

Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.

November 10, 2025
eswar6424

Published: Nov. 10, 2025 at 8:05 a.m. ET Pfizer Inc. pulled off a comeback win, beating out…

Finance

Trump rolls out pricing deal with weight-loss-drug giants Eli Lilly, Novo Nordisk. Analysts say the pact raises more questions than it answers.

November 7, 2025
eswar6424

Jessica Hall is a retirement reporter for MarketWatch. She was an Age Boom Academy Fellow with…

Finance

Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera

November 5, 2025
eswar6424

Management lowers full-year guidance, warns about competition, launches bid for Metsera.

Finance

Medicare recipients may get obesity drugs for just $149 a month under a reported White House deal in the works

November 4, 2025
eswar6424

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk…